Across TCGA pan-cancer cohorts, DUSP23 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DUSP23 data layer compared with 25 for mass-spec protein and 3 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher DUSP23 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DUSP23 expression acts as an unfavorable survival marker.
COAD, UCEC, and LUSC are the cancer types where DUSP23 Mutation most reproducibly stratifies survival.